Gene Query: BIK

Dataset Description Geneva Score
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 64.84
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 64.84
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 32.48
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 22.54
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 17.82
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 17.32
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 17.32
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 16.96
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 13.78
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 13.54
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 12.44
Regulatory network controlling tumor-promoting inflammation in human cancers 12.44
Seletive inhibition of CDK9 in DLBCL cell lines 12.04
Differentially expressed genes post knock down of lincDUSP26 11.98
The landscape of alternative splicing in aggressive prostate cancers 11.37
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 10.83
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 9.59
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 9.54
Transcriptional profiles of normal human mature B cells 8.77
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 8.75
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 8.71
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 8.63
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 8.53
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 8.13
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 7.52
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 7.23
Effect of PRDM11 depletion in U2932 cells 6.85
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.8
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.57
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 6.19
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 6.14
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 6.14
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 6.13
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 5.93
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 5.5
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.48
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.48
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 5.28
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 5.19
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 5.14
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 5.05
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 4.93
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 4.9
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 4.84
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 4.67
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 4.51
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.45
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 4.42
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 4.34
RNA-seq of IL-4 stimulated human keratinocytes 4.06
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.94
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 3.74
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.65
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 3.51
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.5
Gene Expression Profiling of WT and KDM3A Knocked out Cell 3.47
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 3.47
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 3.42
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 3.41
Total RNA sequencing of WT intestinal orgaonids. 3.36
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.29
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.28
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 3.27
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 3.19
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 3.19
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.17
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 3.1
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 3.03
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 3.0
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 2.96
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 2.95
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 2.78
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 2.78
NR2F2 study 2.73
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.73
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.61
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 2.57
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.56
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 2.55
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.49
RNA seq analysis of human Fetal and adult derived Enterospheres 2.46
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 2.42
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 2.4
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 2.4
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 2.39
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 2.39
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 2.34
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 2.32
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 2.29
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.21
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 2.19
MCF10A H-Ras RNA-Seq 2.19
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 2.18
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 2.18
Impact of dieldrin on transcription in Jurkat T cells 2.17
A single-cell transcriptome atlas of the human pancreas 2.09
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 2.09
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 2.08
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.01
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 1.94
Genome wide expression change by RNF168 knocking down in MCF-7 cells 1.88
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 1.88
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.86
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 1.85
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 1.84
Transcriptome-wide identification of CELF2 functional targets in T cells 1.82
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 1.8
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.8
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.8
The comparison of high-throughput single-cell RNA-seq methods 1.78
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 1.76
Identification of long noncoding RNAs regulated by p53 1.74
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 1.73
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 1.7
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.69
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 1.69
Transcription control by the ENL YEATS domain in acute leukemia 1.68
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.68
Gene expression changes upon drug withdrawal (Mel888 cell line) 1.6
Effect of nuclear IL-33 on gene expression 1.55
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.52
Gene expression analysis of breast cancer cell-lines 1.52
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.47
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 1.47
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 1.46
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.4
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 1.38
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 1.38
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 1.37
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.35
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.35
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 1.32
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 1.32
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.31
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 1.3
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 1.29
Paxillin regulates genomic networks in prostate cancer [C4-2] 1.27
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.27
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.27
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 1.24
Paxillin regulates genomic networks in prostate cancer [LNCaP] 1.23
MYCL and EP400 are required for Max and MCPyV mediated gene activation 1.23
RNA-seq of human aneuploid cell lines with Trisomy 21 1.22
Widespread intronic polyadenylation diversifies immune cell transcriptomes 1.21
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.21
RNAseq of T-ALL upon long non coding rna purturbation 1.21
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 1.21
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 1.21
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 1.2
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 1.2
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.2
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.19
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 1.15
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.13
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 1.12
Transcriptomic analysis of human tonsillar TFH subsets 1.11
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 1.1
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 1.09
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.07
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 1.04
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 1.03
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 1.02
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.01
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.01
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 1.0
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.0
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.0
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.99
HNRNPM-regulated splicing dependencies in prostate cancer 0.99
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 0.98
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 0.98
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 0.94
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.94
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.93
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 0.93
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.93
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.92
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 0.91
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.9
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 0.9
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 0.9
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 0.89
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 0.87
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.86
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.86
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 0.85
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.85
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 0.83
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 0.83
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 0.8
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 0.78
Loss of CREBBP results in gene expression repression in lymphoma cells 0.78
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.78
Patient-derived luminal breast cancer xenografts with progestins 0.76
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 0.76
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.76
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 0.76
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.75
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.75
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.75
The role of FAM46C in myeloma cells [sequencing] 0.74
The role of FAM46C in myeloma cells 0.74
Silencing p300 in MCF7 cells to study expression and alternative splicing 0.74
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 0.74
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 0.72
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.72
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.72
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.71
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 0.71
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 0.71
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 0.7
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 0.7
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 0.7
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 0.7
RNAseq analysis of ESRP regulated splicing events in prostate cancer 0.7
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.68
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 0.68
Single-Cell Genotyping of Transcriptomes 0.67
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.67
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.67
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 0.66
HNRNPL and its RNA Targets in Prostate Cancer 0.66
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.64
Gene expression changes associated with resistance to tagraxofusp (SL-401) 0.64
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 0.64
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 0.64
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 0.64
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 0.64
RNA-seq analysis of AML cells in response to ASLAN003 0.63
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 0.63
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 0.62
Identification of a LIF-responsive replication-competent human β cell 0.62
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 0.62
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.62
Transcriptome of EBV-infected gastric cancer cell lines 0.61
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 0.6
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 0.6
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.6
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.6
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 0.59
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 0.59
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 0.59
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.58
RNA-Seq analysis of breast cancer cells after shikonin treatment 0.58
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 0.58
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.58
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.58
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 0.57
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 0.57
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 0.57
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 0.57
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.57
The pioneer factor CEBPA modulates vitamin D signaling 0.57
Transcriptomic and gene ontology profiling of the human corneal cell types 0.57
MHC Transcriptomic landscape at haplotype-specific resolution 0.56
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 0.56
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.56
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.55
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.55
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.54
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 0.54
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 0.54
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 0.53
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.53
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 0.53
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 0.52
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 0.52
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 0.52
A single cell reference map for human blood and tissue T cell activation 0.52
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 0.52
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 0.5
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.5
RNA-seq differential expression studies: more sequence, or more replication? 0.5
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 0.5
ARID1A and ARID1B loss in HCT116 cells 0.5
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 0.49
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 0.49
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 0.49
Hijacking of stress response machinery by oncogenes in acute leukaemia 0.49
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 0.49
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.48
ChIP-seq and RNA-seq from human lymphoma cell lines 0.48
RNA-seq data from human lymphoma cell lines 0.48
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.48
MYCi975 regulates MYC target genes 0.47
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.47
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.47
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.47
Functional significance of the HIV-1 Tat signature amino acid residues 0.47
Total RNA-seq in ALL-SIL upon JQ1 inhibition 0.46
LncRNA-GAS5 negative regulation of YAP-target genes expression 0.46
Electronic cigarettes 0.46
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.45
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.45
BASP1 modifies the Tamoxifen response 0.45
Expression profiles of the four human major ectodermal lineages 0.45
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 0.44
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.44
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 0.44
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 0.43
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.43
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 0.43
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.42
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.42
Selective expression of long non-coding RNAs in a breast cancer cell progression model 0.41
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 0.41
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.41
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.41
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.41
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.4
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.4
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.4
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.4
Transcriptional landscape changes during human embryonic stem cell derivation 0.4
mRNA sequencing of oropharyngeal cancer cell lines 0.38
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 0.38
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 0.38
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 0.38
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.38
RNAseq of cell lines with knocked in ESR1 mutations 0.37
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.37
Targeting MTHFD2 in Acute Myeloid Leukemia 0.37
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.37
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.37
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.37
ARID1A and ARID1B loss in HCT116 and TOV21G cells 0.36
Identification of HOXB13 target genes responsive to BET inhibitors 0.36
CD86 regulates a pro-survival signal in myeloma cells 0.36
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.36
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 0.36
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.35
Integrin signaling regulates YAP/TAZ to control skin homeostasis 0.35
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.34
Characterization of human ILC2 subsets 0.34
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.34
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 0.34
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 0.34
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.34
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.34
Transcriptional profiling of LS1034 cells treated with tepoxalin 0.34
The Genetic Landscape of Diamond-Blackfan Anemia 0.33
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.33
Stem and effector CD8 T-cells from human cancers 0.33
BACH2 in human plasma cell fate decision 0.33
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.32
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.32
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.32
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.32
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.32
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.31
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.31
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.31
Finding missing proteins from epigenetically manipulated human cells 0.31
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 0.31
Effect of BMP inhibition or stimulation of primary human keratinocytes 0.31
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 0.31
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 0.31
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.3
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 0.3
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.29
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.29
Identification of global XBP1s target gene expression in human prostate cancer cells 0.29
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 0.29
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 0.28
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.28
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.27
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.27
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 0.27
H1609088 Human RNA-Sequencing 0.27
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.27
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.27
TAF1 is critical for AE driven leukemogenesis 0.27
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 0.27
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.27
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.27
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.27
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.27
Direct Isolation and Characterization of Human Nephron Progenitors. 0.27
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.26
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.26
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.26
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.26
RNA sequencing of human pancreatic cancer cell lines 0.26
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 0.26
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 0.26
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.25
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.25
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.25
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.25
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.25
Human Treg NaCl stimulation 0.24
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.24
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 0.24
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.24
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.23
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.23
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.23
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.23
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.23
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.23
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.22
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.22
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.22
Gene expression alterations of pancreatic intraepithlial neoplasia 0.22
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.22
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.22
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.22
MicroRNA targetome analysis during HCMV infection 0.22
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.21
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.21
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.2
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.2
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.19
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 0.18
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.18
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.18
Effect of PBK knockdown on C4-2 cell transcriptome 0.18
RNA-sequencing in immortalized human mammary epithelial cells 0.18
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 0.18
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.17
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.17
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.16
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.16
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.15
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 0.14
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 0.14
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 0.14
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.14
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.13
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.13
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.13
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 0.12
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.12
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.12
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.12
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 0.12
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.12
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 0.12
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 0.12
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.11
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.11
Leucegene: AML sequencing (part 6) 0.11
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.11
Epigenome regulation during epidermal lineage commitment 0.11
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.1
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.1
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.09
Human Treg IFNg/IL-10 subpopulations 0.09
Gene expression signatures of innate lymphoid cells from human blood 0.09
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.09
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.09
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.09
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.08
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.08
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.08
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.08
Preclinical model of obesity and ER-positive breast cancer 0.08
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 0.08
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 0.08
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.08
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.08
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.08
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.07
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.07
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.07
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.07
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.07
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 0.07
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 0.07
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.07
An optimization system for isolating and sequencing of single human colon cancer cells 0.07
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.06
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.06
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 0.06
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.05
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.05
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.05
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.05
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.05
Oncogenic roles of ARID5B in T-ALL 0.04
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.04
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 0.04
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.04
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.04
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.04
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.04
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.04
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.03
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.03
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.03
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.03
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 0.03
Leucegene: ALL sequencing 0.03
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.03
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.02
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.02
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.01
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.01
Identification of long noncoding RNAs in T-ALL cell lines 0.01
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation